PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-07-24

Date Title Company
24-Jul-2019 FDA approves first treatment for severe hypoglycemia that can be administered without an injection U.S. Food and Drug Administration
24-Jul-2019 Study Published in American Health Drug Benefits Suggests that Non-Invasive Screening Methods, Including Epi proColon, Could Be A Cost-Effective Option To Help Achieve Target U.S. Colorectal Cancer Screening Rates Epigenomics AG
24-Jul-2019 The Chartis Group Releases White Paper "Getting Beyond the Hype with Apps and Making it a Reality" The Chartis Group
24-Jul-2019 Cipla USA Furthers AMR Stewardship With Acquisition of Key Anti-infective ZEMDRI(TM) (IV Plazomicin) Cipla
24-Jul-2019 ViiV Healthcare announces positive Week 48 results in first study to evaluate treatment switch from TAF-containing regimen with three or more drugs to 2-drug regimen of dolutegravir/lamivudine for HIV-1 infection ViiV Healthcare
24-Jul-2019 ViiV Healthcare presents GEMINI 1 & 2 studies through Week 96 showing 2-drug regimen of dolutegravir plus lamivudine continues to demonstrate high efficacy rates and no cases of treatment emergent resistance ViiV Healthcare
24-Jul-2019 Novo Holdings REPAIR Impact Fund Invests USD 10 million in Curza and Spero Novo Holdings
24-Jul-2019 Novel Drug Being Developed for HIV Prevention and Cancer Indications Demonstrates Best-in-Class Potency Orion Biotechnology
24-Jul-2019 Phase II Clinical Trial Update in Patients with COPD Synairgen plc
24-Jul-2019 Horizon Discovery Group plc Trading Update Horizon Discovery Group plc
24-Jul-2019 Merck and Eisai Receive Third Breakthrough Therapy Designation from FDA for KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination Treatment Merck
24-Jul-2019 Merck Presents Early Evidence on Extended Delivery of Investigational Anti-HIV-1 Agent Islatravir (MK-8591) via Subdermal Implant Merck
24-Jul-2019 Johnson & Johnson Announces New Clinical Data on Mosaic-based HIV Preventive Vaccine Regimen The Janssen Pharmaceutical Companies of Johnson & Johnson
24-Jul-2019 Novel Drug Being Developed for HIV Prevention and Cancer Indications Demonstrates Best-in-Class Potency Orion Biotechnology
24-Jul-2019 FDA takes action to protect patients from risk of certain textured breast implants; requests Allergan voluntarily recall certain breast implants and tissue expanders from market U.S. Food and Drug Administration
24-Jul-2019 3P Biopharmaceuticals welcomes Keensight Capital as majority shareholder 3PBiopharmaceuticals
24-Jul-2019 Complimentary Webinar: Role of LIMS in Overcoming Biorepository Operational Data Management Challenges CloudLIMS
24-Jul-2019 Cancer Stem Cells Market - Global Industry Size, Share, Trends, and Forecast 2018-2026 Wired Hearld
24-Jul-2019 Emergency Kit Market Revenue Predicted to Go Up by 2018 to 2026 Wired Hearld
24-Jul-2019 Flavored Veterinary Medication Market Cost Analysis, Strategy and Growth Factor- Global Forecast 2018 - 2026 Wired Hearld